An alternative approach has been opened since the discovery that all tumor relevant mutations in IDH1 and IDH2 result in a neomorphic enzyme activity ultimately leading to a dramatic increase of intracellular 2HG [9]. The gene discussed is IDH1; the disease is neoplasm.